Maravai LifeSciences, Inc. plans for William Trey Martin, III to serve as President of Maravai's Biologics Safety Testing Segment beginning December 5, 2022, and expects that Martin will assume the role of Chief Executive Officer of Maravai LifeSciences on July 27, 2023. Carl Hull, Maravai's co-founder, will continue to serve as Maravai's Interim Chief Executive Officer.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.32 USD | +1.89% | +8.22% | +72.82% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+72.82% | 1.5B | |
-31.90% | 9.3B | |
-6.25% | 3.1B | |
-13.96% | 2.17B | |
-16.83% | 1.75B | |
+29.17% | 807M | |
-2.62% | 759M | |
-26.33% | 532M | |
+4.97% | 313M | |
-14.35% | 191M |
- Stock Market
- Equities
- MRVI Stock
- News Maravai LifeSciences Holdings, Inc.
- Maravai LifeSciences Holdings, Inc. Announces Executive Changes